Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 30
Summary
- Conditions
- Pancreatic Adenocarcinoma
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03245541
- Collaborators
- AstraZeneca
- Cedars-Sinai Medical Center
- Investigators
- Principal Investigator: Eileen O'Reilly, MD Memorial Sloan Kettering Cancer Center
Get Well Soon